{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:08:06Z","timestamp":1789610886997,"version":"build-2803163510"},"reference-count":77,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006735","name":"NYC Health + Hospitals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Neoplasia"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bneo.2026.100217","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T17:22:23Z","timestamp":1773163343000},"page":"100217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Artificial intelligence\u2013based prognostic models in acute myeloid leukemia: systematic review and meta-analysis"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4043-7518","authenticated-orcid":false,"given":"Xiaoyi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simo","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manasa","family":"Anipindi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cho-Hao","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisha","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.bneo.2026.100217_bib1","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1001\/jamadermatol.2019.0052","article-title":"Association of leukemia cutis with survival in acute myeloid leukemia","volume":"155","author":"Wang","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"suppl 1","key":"10.1016\/j.bneo.2026.100217_bib2","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1182\/blood-2023-179325","article-title":"1- and 5-year survival for adults with acute myeloid leukaemia and 30-day mortality after initial systemic anti-cancer therapy, with an exploration of factors associated with poorer outcomes: data from a national registry in England, 2013-2020","volume":"142","author":"Liu","year":"2023","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.bneo.2026.100217_bib3","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1182\/bloodadvances.2020001904","article-title":"Prognostic impact of the ELN2017 risk classification in patients with AML receiving allogeneic transplantation","volume":"4","author":"Grimm","year":"2020","journal-title":"Blood Adv"},{"issue":"6","key":"10.1016\/j.bneo.2026.100217_bib4","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/s41375-023-01884-2","article-title":"Validation and refinement of the 2022 European LeukemiaNet genetic risk stratification of acute myeloid leukemia","volume":"37","author":"Rausch","year":"2023","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.bneo.2026.100217_bib5","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41408-022-00764-9","article-title":"Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation","volume":"12","author":"Jentzsch","year":"2022","journal-title":"Blood Cancer J"},{"issue":"13","key":"10.1016\/j.bneo.2026.100217_bib6","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.3390\/cancers15133512","article-title":"Modern risk stratification of acute myeloid leukemia in 2023: integrating established and emerging prognostic factors","volume":"15","author":"Boscaro","year":"2023","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.bneo.2026.100217_bib7","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1038\/s41375-020-0806-0","article-title":"Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia","volume":"34","author":"Herold","year":"2020","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.bneo.2026.100217_bib8","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/bjh.15916","article-title":"Prognostic significance of mutation profile at diagnosis and mutation persistence during disease remission in adult acute myeloid leukaemia patients","volume":"186","author":"Folta","year":"2019","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.bneo.2026.100217_bib9","doi-asserted-by":"crossref","first-page":"e541","DOI":"10.1016\/S2352-3026(20)30121-6","article-title":"Machine learning in haematological malignancies","volume":"7","author":"Radakovich","year":"2020","journal-title":"Lancet Haematol"},{"issue":"1","key":"10.1016\/j.bneo.2026.100217_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11899-023-00716-5","article-title":"Unlocking the potential of artificial intelligence in acute myeloid leukemia and myelodysplastic syndromes","volume":"19","author":"Alhajahjeh","year":"2024","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.bneo.2026.100217_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fdata.2024.1402926","article-title":"Artificial intelligence for the detection of acute myeloid leukemia from microscopic blood images; a systematic review and meta-analysis","volume":"7","author":"Al-Obeidat","year":"2025","journal-title":"Frontiers in Big Data"},{"issue":"3","key":"10.1016\/j.bneo.2026.100217_bib12","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3324\/haematol.2021.280027","article-title":"Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning","volume":"108","author":"Eckardt","year":"2023","journal-title":"Haematologica"},{"issue":"23","key":"10.1016\/j.bneo.2026.100217_bib13","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1182\/bloodadvances.2020002997","article-title":"Application of machine learning in the management of acute myeloid leukemia: current practice and future prospects","volume":"4","author":"Eckardt","year":"2020","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.bneo.2026.100217_bib14","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41390-024-03494-9","article-title":"Machine learning in paediatric haematological malignancies: a systematic review of prognosis, toxicity and treatment response models","volume":"97","author":"Gurumurthy","year":"2025","journal-title":"Pediatr Res"},{"issue":"4","key":"10.1016\/j.bneo.2026.100217_bib15","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1001\/jamaoncol.2022.7605","article-title":"Allogeneic hematopoietic cell transplantation vs standard consolidation chemotherapy in patients with intermediate-risk acute myeloid leukemia: a randomized clinical trial","volume":"9","author":"Bornh\u00e4user","year":"2023","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.bneo.2026.100217_bib16","doi-asserted-by":"crossref","first-page":"e0324380","DOI":"10.1371\/journal.pone.0324380","article-title":"Integrative analysis of epigenetic subtypes in acute myeloid leukemia: a multi-center study combining machine learning for prognostic and therapeutic insights","volume":"20","author":"Li","year":"2025","journal-title":"PLoS One"},{"issue":"17","key":"10.1016\/j.bneo.2026.100217_bib17","article-title":"Molecular precision medicine: multi-omics-based stratification model for acute myeloid leukemia","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"issue":"5","key":"10.1016\/j.bneo.2026.100217_bib18","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3390\/jcm14051670","article-title":"Applications of artificial intelligence in acute promyelocytic leukemia: an avenue of opportunities? a systematic review","volume":"14","author":"G\u0103man","year":"2025","journal-title":"J Clin Med"},{"issue":"13","key":"10.1016\/j.bneo.2026.100217_bib19","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.3390\/cancers15133512","article-title":"Modern risk stratification of acute myeloid leukemia in 2023: integrating established and emerging prognostic factors","volume":"15","author":"Boscaro","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.bneo.2026.100217_bib20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13045-021-01118-x","article-title":"Precision oncology in AML: validation of the prognostic value of the knowledge bank approach and suggestions for improvement","volume":"14","author":"Bill","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.bneo.2026.100217_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2024.107437","article-title":"Artificial intelligence-based prediction models for acute myeloid leukemia using real-life data: A DATAML registry study","volume":"136","author":"Didi","year":"2024","journal-title":"Leuk Res"},{"key":"10.1016\/j.bneo.2026.100217_bib51","doi-asserted-by":"crossref","first-page":"e2100156","DOI":"10.1200\/CCI.21.00156","article-title":"Machine learning to predict risk of relapse using cytologic image markers in patients with acute myeloid leukemia posthematopoietic cell transplantation","volume":"6","author":"Arabyarmohammadi","year":"2022","journal-title":"JCO Clin Cancer Inform"},{"issue":"7","key":"10.1016\/j.bneo.2026.100217_bib45","doi-asserted-by":"crossref","first-page":"e0254976","DOI":"10.1371\/journal.pone.0254976","article-title":"Survival prognostic factors in patients with acute myeloid leukemia using machine learning techniques","volume":"16","author":"Karami","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bneo.2026.100217_bib50","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s12885-025-13658-3","article-title":"Machine learning-based bulk RNA analysis reveals a prognostic signature of 13 cell death patterns and potential therapeutic target of SMAD3 in acute myeloid leukemia","volume":"25","author":"Bao","year":"2025","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.bneo.2026.100217_bib25","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1038\/s41598-024-53306-7","article-title":"Development and validation of a cuproptosis-related prognostic model for acute myeloid leukemia patients using machine learning with stacking","volume":"14","author":"Wang","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.bneo.2026.100217_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-68755-3","article-title":"Machine learning-based biomarker screening for acute myeloid leukemia prognosis and therapy from diverse cell-death patterns","volume":"14","author":"Qin","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.bneo.2026.100217_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1558496","article-title":"Integrated multiomics analysis and machine learning refine neutrophil extracellular trap-related molecular subtypes and prognostic models for acute myeloid leukemia","volume":"16","author":"Zhong","year":"2025","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.bneo.2026.100217_bib28","doi-asserted-by":"crossref","first-page":"e2200044","DOI":"10.1200\/CCI.22.00044","article-title":"Predicting in-hospital mortality after acute myeloid leukemia therapy: through supervised machine learning algorithms","volume":"6","author":"Siddiqui","year":"2022","journal-title":"JCO Clin Cancer Inform"},{"issue":"10","key":"10.1016\/j.bneo.2026.100217_bib52","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.4049\/jimmunol.2300827","article-title":"High-dimensional immune profiles and machine learning may predict acute myeloid leukemia relapse early following transplant","volume":"213","author":"Short","year":"2024","journal-title":"J Immunol"},{"key":"10.1016\/j.bneo.2026.100217_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.108735","article-title":"Machine learning and integrative multi-omics network analysis for survival prediction in acute myeloid leukemia","volume":"178","author":"Kosvyra","year":"2024","journal-title":"Comput Biol Med"},{"issue":"8","key":"10.1016\/j.bneo.2026.100217_bib29","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1182\/bloodadvances.2018030726","article-title":"A parsimonious 3-gene signature predicts clinical outcomes in an acute myeloid leukemia multicohort study","volume":"3","author":"Wagner","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.bneo.2026.100217_bib30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ebiom.2018.10.042","article-title":"Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome","volume":"37","author":"Ko","year":"2018","journal-title":"EBioMedicine"},{"issue":"7","key":"10.1016\/j.bneo.2026.100217_bib31","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/s41417-024-00788-2","article-title":"Unveiling mitochondrial and ribosomal gene deregulation and tumor microenvironment dynamics in acute myeloid leukemia","volume":"31","author":"Ma","year":"2024","journal-title":"Cancer Gene Ther"},{"issue":"3","key":"10.1016\/j.bneo.2026.100217_bib39","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00011-023-01839-4","article-title":"CD8 + T cell-based molecular subtypes with heterogeneous immune landscapes and clinical significance in acute myeloid leukemia","volume":"73","author":"Zhong","year":"2024","journal-title":"Inflamm Res"},{"key":"10.1016\/j.bneo.2026.100217_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1040661","article-title":"A transient receptor potential channel-related model based on machine learning for evaluating tumor microenvironment and immunotherapeutic strategies in acute myeloid leukemia","volume":"13","author":"Hua","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.bneo.2026.100217_bib33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12911-022-01791-z","article-title":"Survival prediction in acute myeloid leukemia using gene expression profiling","volume":"22","author":"Lai","year":"2022","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.bneo.2026.100217_bib34","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/5113990","article-title":"Machine learning-based integrated analysis of PANoptosis patterns in acute myeloid leukemia reveals a signature predicting survival and immunotherapy","volume":"2024","author":"Tang","year":"2024","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.bneo.2026.100217_bib35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bcmd.2019.03.008","article-title":"Construction of prognostic risk prediction model based on high-throughput sequencing expression profile data in childhood acute myeloid leukemia","volume":"77","author":"Niu","year":"2019","journal-title":"Blood Cells Mol Dis"},{"issue":"6","key":"10.1016\/j.bneo.2026.100217_bib36","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/jleuko\/qiae151","article-title":"MT1E in AML: a gateway to understanding regulatory cell death and immunotherapeutic responses","volume":"116","author":"Zhuang","year":"2024","journal-title":"J Leukoc Biol"},{"issue":"6","key":"10.1016\/j.bneo.2026.100217_bib37","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s12094-022-03069-2","article-title":"A novel prognostic model of methylation-associated genes in acute myeloid leukemia","volume":"25","author":"Chen","year":"2023","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.bneo.2026.100217_bib38","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7826393","article-title":"Five EMT-related gene signatures predict acute myeloid leukemia patient outcome","volume":"2022","author":"Qi","year":"2022","journal-title":"Dis Markers"},{"issue":"3","key":"10.1016\/j.bneo.2026.100217_bib77","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3324\/haematol.2017.178442","article-title":"A 29-gene and cytogenetic score for the prediction of resistance to induction treatment in acute myeloid leukemia","volume":"103","author":"Herold","year":"2018","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.bneo.2026.100217_bib21","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M18-1377","article-title":"PROBAST: a tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration","volume":"170","author":"Moons","year":"2019","journal-title":"Ann Intern Med"},{"issue":"pt A","key":"10.1016\/j.bneo.2026.100217_bib22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cct.2015.09.002","article-title":"Meta-analysis in clinical trials revisited","volume":"45","author":"DerSimonian","year":"2015","journal-title":"Contemp Clin Trials"},{"issue":"9","key":"10.1016\/j.bneo.2026.100217_bib23","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1177\/0962280218785504","article-title":"A framework for meta-analysis of prediction model studies with binary and time-to-event outcomes","volume":"28","author":"Debray","year":"2019","journal-title":"Stat Methods Med Res"},{"issue":"4","key":"10.1016\/j.bneo.2026.100217_bib24","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/sim.6632","article-title":"Misunderstandings about Q and 'Cochran's Q test' in meta-analysis","volume":"35","author":"Hoaglin","year":"2016","journal-title":"Stat Med"},{"issue":"10","key":"10.1016\/j.bneo.2026.100217_bib42","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/jnci\/djy021","article-title":"Development and validation of a novel RNA sequencing-based prognostic score for acute myeloid leukemia","volume":"110","author":"Wang","year":"2018","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.bneo.2026.100217_bib43","doi-asserted-by":"crossref","first-page":"9609","DOI":"10.1007\/s00432-023-04871-3","article-title":"Analysis of prognostic biomarker models and immune microenvironment in acute myeloid leukemia by integrative bioinformatics","volume":"149","author":"Wang","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.bneo.2026.100217_bib44","article-title":"Construction of a solid Cox model for AML patients based on multiomics bioinformatic analysis","volume":"12","author":"Li","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.bneo.2026.100217_bib46","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12874-022-01577-x","article-title":"Methodological conduct of prognostic prediction models developed using machine learning in oncology: a systematic review","volume":"22","author":"Dhiman","year":"2022","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.bneo.2026.100217_bib47","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","first-page":"241","article-title":"Analysing data and undertaking meta-analyses","author":"Deeks","year":"2019"},{"key":"10.1016\/j.bneo.2026.100217_bib48","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d549","article-title":"Interpretation of random effects meta-analyses","volume":"342","author":"Riley","year":"2011","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.bneo.2026.100217_bib49","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010247","article-title":"Plea for routinely presenting prediction intervals in meta-analysis","volume":"6","author":"IntHout","year":"2016","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.bneo.2026.100217_bib53","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.tibtech.2017.02.012","article-title":"Why batch effects matter in omics data, and how to avoid them","volume":"35","author":"Goh","year":"2017","journal-title":"Trends Biotechnol"},{"issue":"3","key":"10.1016\/j.bneo.2026.100217_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17030483","article-title":"Machine learning methods in clinical flow cytometry","volume":"17","author":"Spies","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bneo.2026.100217_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2025.110394","article-title":"A machine learning framework for cross-institute standardized analysis of flow cytometry in differentiating acute myeloid leukemia from non-neoplastic conditions","volume":"193","author":"Wang","year":"2025","journal-title":"Comput Biol Med"},{"issue":"10","key":"10.1016\/j.bneo.2026.100217_bib56","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000041766","article-title":"Big data analytics and machine learning in hematology: transformative insights, applications and challenges","volume":"104","author":"Obeagu","year":"2025","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.bneo.2026.100217_bib57","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbae331","article-title":"Comparative analysis of integrative classification methods for multi-omics data","volume":"25","author":"Novoloaca","year":"2024","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.bneo.2026.100217_bib58","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1016\/j.csbj.2021.06.030","article-title":"Integration strategies of multi-omics data for machine learning analysis","volume":"19","author":"Picard","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.bneo.2026.100217_bib59","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3389\/fonc.2020.01065","article-title":"Integrative network fusion: a multi-omics approach in molecular profiling","volume":"10","author":"Chierici","year":"2020","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.bneo.2026.100217_bib60","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/CCO.0000000000000965","article-title":"Recent advances in precision medicine for acute myeloid leukemia","volume":"35","author":"Hern\u00e1ndez-S\u00e1nchez","year":"2023","journal-title":"Curr Opin Oncol"},{"issue":"1","key":"10.1016\/j.bneo.2026.100217_bib61","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1038\/s41467-022-32103-8","article-title":"Unified classification and risk-stratification in acute myeloid leukemia","volume":"13","author":"Tazi","year":"2022","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.bneo.2026.100217_bib62","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbad200","article-title":"Precision oncology: a review to assess interpretability in several explainable methods","volume":"24","author":"Gimeno","year":"2023","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.bneo.2026.100217_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.artmed.2023.102616","article-title":"How does the model make predictions? A systematic literature review on the explainability power of machine learning in healthcare","volume":"143","author":"Allgaier","year":"2023","journal-title":"Artif Intell Med"},{"issue":"1","key":"10.1016\/j.bneo.2026.100217_bib64","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1038\/s41598-021-81773-9","article-title":"Verifying explainability of a deep learning tissue classifier trained on RNA-seq data","volume":"11","author":"Yap","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.bneo.2026.100217_bib65","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.bneo.2026.100217_bib66","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-082505","article-title":"PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods","volume":"388","author":"Moons","year":"2025","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.bneo.2026.100217_bib67","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69250-1","article-title":"Federated learning in medicine: facilitating multi-institutional collaborations without sharing patient data","volume":"10","author":"Sheller","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.bneo.2026.100217_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2023.104338","article-title":"The need for multimodal health data modeling: a practical approach for a federated-learning healthcare platform","volume":"141","author":"Cremonesi","year":"2023","journal-title":"J Biomed Inform"},{"issue":"5","key":"10.1016\/j.bneo.2026.100217_bib69","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbad269","article-title":"AFEI: adaptive optimized vertical federated learning for heterogeneous multi-omics data integration","volume":"24","author":"Wang","year":"2023","journal-title":"Brief Bioinform"},{"issue":"12","key":"10.1016\/j.bneo.2026.100217_bib70","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1038\/s41591-020-1089-8","article-title":"Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial","volume":"26","author":"Burd","year":"2020","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.bneo.2026.100217_bib71","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.3390\/ijms24054790","article-title":"Targeting measurable residual disease (MRD) in acute myeloid leukemia (AML): moving beyond prognostication","volume":"24","author":"Tiong","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.bneo.2026.100217_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073887","article-title":"New perspectives in treating acute myeloid leukemia: driving towards a patient-tailored strategy","volume":"23","author":"Andreozzi","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"21","key":"10.1016\/j.bneo.2026.100217_bib73","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1182\/blood.2022015853","article-title":"Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia","volume":"140","author":"Duncavage","year":"2022","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bneo.2026.100217_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmoldx.2021.09.009","article-title":"Electronic health records and genomics: perspectives from the Association for Molecular Pathology Electronic Health Record (EHR) Interoperability for Clinical Genomics Data Working Group","volume":"24","author":"Carter","year":"2022","journal-title":"J Mol Diagn"},{"issue":"12","key":"10.1016\/j.bneo.2026.100217_bib75","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.3324\/haematol.2020.263806","article-title":"Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project","volume":"106","author":"Sargas","year":"2021","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.bneo.2026.100217_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2020.101192","article-title":"Acute myeloid leukemia and artificial intelligence, algorithms and new scores","volume":"33","author":"Radakovich","year":"2020","journal-title":"Best Pract Res Clin Haematol"}],"container-title":["Blood Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328026000282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328026000282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T16:25:25Z","timestamp":1779294325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950328026000282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":77,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2950328026000282"],"URL":"https:\/\/doi.org\/10.1016\/j.bneo.2026.100217","relation":{},"ISSN":["2950-3280"],"issn-type":[{"value":"2950-3280","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artificial intelligence\u2013based prognostic models in acute myeloid leukemia: systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Blood Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bneo.2026.100217","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100217"}}